This review presents the current state of the art regarding multiparametric magnetic
resonance (MR) imaging of prostate cancer. Technical requirements and clinical indications …

CONTEXT: Prostate cancer (PCa) remains an increasingly common malignancy worldwide.
The optimal management of clinically localized, early-stage disease remains unknown, and …

BACKGROUND: Multiparametric magnetic resonance imaging (mpMRI) may have a role in
detecting clinically significant prostate cancer in men with raised serum prostate-specific …

Context There is great interest in using magnetic resonance imaging (MRI) for men on active
surveillance for prostate cancer. Objective To systematically review evidence regarding the …

Purpose We assessed outcomes of men with prostate cancer enrolled in active surveillance.
Patients and Methods Since 1995, a total of 769 men diagnosed with prostate cancer have …

Context The notion of insignificant prostate cancer (Ins-PCa) has progressively emerged in
the past two decades. The clinical relevance of such a definition was based on the fact that …

Widespread prostate-specific antigen (PSA)–based screening and aggressive treatment of
prostate cancer have reduced mortality rates substantially, but both remain controversial in …

Background Multiparametric magnetic resonance imaging (MP-MRI) may improve the
detection of clinically significant prostate cancer (PCa). Objective To compare MP-MRI …

Purpose: The biology of prostate cancer may be influenced by the index lesion. The
definition of index lesion volume is important for appropriate decision making, especially for …

Background The diagnosis of prostate cancer has long been plagued by the absence of an
imaging tool that reliably detects and localises significant tumours. Recent evidence …